The U.S. healthcare system is not very popular, according to a recent Gallup poll. In fact, 70 percent of Americans describe the system as being “in a state of crisis” or “having major problems,” the poll found.

An aggressive flu season in 2017 contributed to 145,000 global deaths, according to a recent study published by The Lancet. The high figure echoes early estimates of 80,000 flu deaths in the United States in the same year.

Drug prices are going up not just because of new innovations in medications, as the pharma industry frequently cites, but also because the industry is pricing existing products higher, according to a Health Affairs study.

Deaths from cancer in the United States declined 27 percent from a peak in 1991, according to the American Cancer Society.

Medicare’s Hospital Readmissions Reduction Program (HRRP) has been given a lot of credit for trimming readmission rates, but the real results may be far less impressive, according to a recent study published in Health Affairs.

Consumers are used to getting what they need easily with the click of a button, including ordering and receiving their prescription medications through the mail. But those deliveries may be risky if medicines aren't stored and transported carefully, according to a report from NPR.

The newest bundled payment program is a money-saver for CMS and Medicare, according to a recent study published in the New England Journal of Medicine. The findings are on par with previous studies that revealed other bundles are achieving their goals of lowering healthcare costs and improving care outcomes.

Johns Hopkins doctors invented a checklist that has saved thousands of lives, but they sometimes fail to follow the principles themselves, according to an investigation by the Tampa Bay Times.

Healthcare stakeholders dealt with a slurry of new regulations, policy shifts and mega deals across the industry in 2018. After a whirlwind of a year, we’ve rounded up our most popular stories from 2018.

The U.S. government has jumped into a False Claims Act lawsuit stemming from a whistleblower against Sutter Health, a healthcare services company based in California, and its affiliate Palo Alto Medical Foundation.

After coming under fire for funding research projects with clear conflicts of interest behind those conducting them, the National Institutes of Health has revised how it will fund future studies.

The United States pays far more for prescription drugs than other countries, but health outcomes aren’t much better—and sometimes, they’re worse—according to Axios.